Technical Analysis for HROW - Harrow Health, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Up |
| Historical HROW trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 20 DMA | Bullish | 0.00% | |
| Pocket Pivot | Bullish Swing Setup | 0.00% | |
| Narrow Range Bar | Range Contraction | 8.31% | |
| Down 3 Days in a Row | Weakness | 8.31% | |
| Narrow Range Bar | Range Contraction | 7.67% | |
| NR7 | Range Contraction | 7.67% | |
| Inside Day | Range Contraction | 7.67% | |
| 20 DMA Resistance | Bearish | 6.10% | |
| 20 DMA Resistance | Bearish | 3.55% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | 3.55% |
Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App
| Alert | Time |
|---|---|
| Up 5% | about 10 hours ago |
| Possible Pocket Pivot | about 10 hours ago |
| Up 1 ATR | about 10 hours ago |
| 10 DMA Support | about 12 hours ago |
| 60 Minute Opening Range Breakout | about 12 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/10/2021
Harrow Health, Inc. Description
Harrow Health, Inc., formerly Imprimis Pharmaceuticals, Inc., is engaged in the development, production and dispensing of compounded pharmaceuticals. The Company operates through the business of developing drug therapies and providing such therapies through sterile and non-sterile pharmaceutical compounding services segment. The Company owns, markets and dispenses a portfolio of compounded therapeutic in several therapeutic areas, including ophthalmology, urology, otolaryngology and infectious diseases. The Company is also developing Custom Compounding Choice business, which is focused on developing and dispensing a portfolio of non-proprietary compounded drugs for humans and animals in therapeutic areas that may be overlooked by commercial pharmaceutical companies. The Company also offers customizable compounding products that consist of sterile injectable and non-sterile integrative medicine therapies that are used in various therapeutic areas.
Classification
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Pharmaceutical Infectious Diseases Pharmaceuticals Pharmacy Urology Ophthalmology Pharmaceutical Sciences Drug Therapies Compounding
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 11.1 |
| 52 Week Low | 3.75 |
| Average Volume | 186,450 |
| 200-Day Moving Average | 6.59 |
| 50-Day Moving Average | 7.89 |
| 20-Day Moving Average | 6.88 |
| 10-Day Moving Average | 6.88 |
| Average True Range | 0.42 |
| ADX | 22.89 |
| +DI | 21.60 |
| -DI | 20.50 |
| Chandelier Exit (Long, 3 ATRs ) | 6.74 |
| Chandelier Exit (Short, 3 ATRs ) | 7.26 |
| Upper Bollinger Band | 7.49 |
| Lower Bollinger Band | 6.28 |
| Percent B (%b) | 0.84 |
| BandWidth | 17.68 |
| MACD Line | -0.21 |
| MACD Signal Line | -0.30 |
| MACD Histogram | 0.0871 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 8.09 | ||||
| Resistance 3 (R3) | 8.02 | 7.68 | 7.96 | ||
| Resistance 2 (R2) | 7.68 | 7.48 | 7.72 | 7.91 | |
| Resistance 1 (R1) | 7.49 | 7.36 | 7.59 | 7.56 | 7.87 |
| Pivot Point | 7.16 | 7.16 | 7.21 | 7.19 | 7.16 |
| Support 1 (S1) | 6.97 | 6.96 | 7.06 | 7.04 | 6.73 |
| Support 2 (S2) | 6.63 | 6.83 | 6.67 | 6.69 | |
| Support 3 (S3) | 6.44 | 6.63 | 6.64 | ||
| Support 4 (S4) | 6.51 |
